New Disease Registries Support Comparative Effectiveness Research Priorities
RemedyMD’s solutions address Institute of Medicine’s top 100 priorities and shift focus toward use of more comprehensive scientific evidence.
Salt Lake City, UT, October 25, 2009 --(PR.com)-- RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease, and clinical registries in the next 90 days.
Details about the registry: www.remedymd.com/cer100/
Developed to support the Institute of Medicine’s 100 top priorities for comparative effectiveness research (CER), these registries allow users to:
· Access existing data stores
· Easily collect new data elements
· Report across all phenotypic and genotypic data simultaneously
As a result, clinicians and researchers will be able to dramatically improve their effectiveness as they search for which interventions are most appropriate for specific patient populations.
“Our experience has shown that when you view and report across all data types at the same time, you discover patterns and associations that were previously indistinguishable using traditional methodologies”, said Gary Kennedy, Founder and CEO of RemedyMD.
RemedyMD’s disease registry software effectively utilizes a combination of applications, tools and data infrastructure enabling clinicians and researchers to electronically collect and validate data, access and leverage other non-centralized data stores, while reporting and visualizing trends across all data types simultaneously.
“We’ve invested heavily over the past several years developing a platform that allows us to quickly create and personalize specialty-specific registries that address the requirement of AHRQ grants for CER”, said Adam Slovik, President and COO of RemedyMD. “Our Mosaic platform allows researchers to leverage disparate data sources, collaborate with colleagues and personalize research initiatives all without the help of IT.”
For more information about comparative effectiveness research and clinical registries visit: http://www.remedymd.com/cer100/.
RemedyMD Registry Resources:
Ways to Leverage New Registries: http://www.remedymd.com/cer100/
Comparative Effectiveness Research: www.remedymd.com/cer_home.html
Clinical Registries: www.remedymd.com/registries_home.html
Disease Registry Software: http://www.remedymd.com/registries_home.html
Institute of Medicine’s Top 100 Priorities for CER: www.remedymd.com/cer_kit
About RemedyMD
RemedyMD® is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, disease, and patient registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider’s preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes. For more information, visit www.RemedyMD.com.
###
Details about the registry: www.remedymd.com/cer100/
Developed to support the Institute of Medicine’s 100 top priorities for comparative effectiveness research (CER), these registries allow users to:
· Access existing data stores
· Easily collect new data elements
· Report across all phenotypic and genotypic data simultaneously
As a result, clinicians and researchers will be able to dramatically improve their effectiveness as they search for which interventions are most appropriate for specific patient populations.
“Our experience has shown that when you view and report across all data types at the same time, you discover patterns and associations that were previously indistinguishable using traditional methodologies”, said Gary Kennedy, Founder and CEO of RemedyMD.
RemedyMD’s disease registry software effectively utilizes a combination of applications, tools and data infrastructure enabling clinicians and researchers to electronically collect and validate data, access and leverage other non-centralized data stores, while reporting and visualizing trends across all data types simultaneously.
“We’ve invested heavily over the past several years developing a platform that allows us to quickly create and personalize specialty-specific registries that address the requirement of AHRQ grants for CER”, said Adam Slovik, President and COO of RemedyMD. “Our Mosaic platform allows researchers to leverage disparate data sources, collaborate with colleagues and personalize research initiatives all without the help of IT.”
For more information about comparative effectiveness research and clinical registries visit: http://www.remedymd.com/cer100/.
RemedyMD Registry Resources:
Ways to Leverage New Registries: http://www.remedymd.com/cer100/
Comparative Effectiveness Research: www.remedymd.com/cer_home.html
Clinical Registries: www.remedymd.com/registries_home.html
Disease Registry Software: http://www.remedymd.com/registries_home.html
Institute of Medicine’s Top 100 Priorities for CER: www.remedymd.com/cer_kit
About RemedyMD
RemedyMD® is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, disease, and patient registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider’s preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes. For more information, visit www.RemedyMD.com.
###
Contact
RemedyMD
Lane Peterson
801-733-3383
www.RemedyMD.com
Contact
Lane Peterson
801-733-3383
www.RemedyMD.com
Categories